206 related articles for article (PubMed ID: 26000385)
1. Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
J Biomed Nanotechnol; 2014 Nov; 10(11):3253-68. PubMed ID: 26000385
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
[TBL] [Abstract][Full Text] [Related]
3. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
[TBL] [Abstract][Full Text] [Related]
4. Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model.
Mukherjee S; Sau S; Madhuri D; Bollu VS; Madhusudana K; Sreedhar B; Banerjee R; Patra CR
J Biomed Nanotechnol; 2016 Jan; 12(1):165-81. PubMed ID: 27301182
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
6. Galactoxyloglucan-doxorubicin nanoparticles exerts superior cytotoxic effects on cancer cells-A mechanistic and in silico approach.
Joseph MM; G A; T K M; T T S
Int J Biol Macromol; 2016 Nov; 92():20-29. PubMed ID: 27373427
[TBL] [Abstract][Full Text] [Related]
7. Bioinspired Nano-Prodrug with Enhanced Tumor Targeting and Increased Therapeutic Efficiency.
Chen WH; Lei Q; Yang CX; Jia HZ; Luo GF; Wang XY; Liu G; Cheng SX; Zhang XZ
Small; 2015 Oct; 11(39):5230-42. PubMed ID: 26285687
[TBL] [Abstract][Full Text] [Related]
8. Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety.
Huang K; Shi B; Xu W; Ding J; Yang Y; Liu H; Zhuang X; Chen X
Acta Biomater; 2015 Nov; 27():179-193. PubMed ID: 26320542
[TBL] [Abstract][Full Text] [Related]
9. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
[TBL] [Abstract][Full Text] [Related]
10. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo chemo-phototherapy of magnetic TiO2 drug delivery system formed by pH-sensitive coordination bond.
Zhang H; Ji Y; Chen Q; Zhu X; Zhang X; Tan Z; Tian Q; Yang X; Zhang Z
J Biomater Appl; 2016 Oct; 31(4):568-581. PubMed ID: 27334128
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2014 Apr; 116():219-27. PubMed ID: 24486833
[TBL] [Abstract][Full Text] [Related]
14. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
[TBL] [Abstract][Full Text] [Related]
15. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates.
Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
Raja MA; Arif M; Feng C; Zeenat S; Liu CG
J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
[TBL] [Abstract][Full Text] [Related]
18. PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties.
Joseph MM; Aravind SR; Varghese S; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2013 Apr; 104():32-9. PubMed ID: 23298585
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
